QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
? ??? ???? – ???????? ?? ??????? ?????? ?? ???????! ?
The entire team here at Quantify is extremely excited to announce that we are opening our doors in Finland. Even though we have a long history of working with Finnish RWE and market access, our new local presence will help us provide stronger, more personalised services to our local clients and increasingly powerful RWE solutions for our global clients.
Are you located in Finland, experienced in RWE or market access, […]
How much is TLV willing to pay for a QALY in Sweden?
Understanding how payers value a quality-adjusted life year (QALY) is crucial. We often are asked about the Swedish payer TLV’s willingness to pay (WTP) thresholds for one QALY, and whether the usually cited levels of WTP by severity are used in practice. Have another look at our ISPOR poster where we looked at 101 decisions since 2014 to see which incremental cost-effectiveness ratio (ICER) levels were accepted across […]
New study published on ICD-11 requirements
In Quantify’s latest publication co-authored by Christoph Abé, PhD, the research group conducted a field trial focused on the ICD-11 chapter on mental disorders which contains new diagnoses for impulse control disorders.
Using a vignette-based methodology, this field study examined the ability of more than 1,000 mental health professionals across the World Health Organization‘s Global Clinical Practice Network to apply the new […]
Kicking off 2024 with a bang!?
This Monday the Quantify Research teams across the globe got together for our annual January Kick-Off.
We celebrated our successes from last year whilst looking ahead at a very exciting 2024. We wrapped up the day with a burning and planting ceremony before our teams headed out to a few different locations for the evening.
We are looking forward to keeping all of you updated […]